ranolazine has been researched along with Liver Dysfunction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdallah, H; Jerling, M | 1 |
1 trial(s) available for ranolazine and Liver Dysfunction
| Article | Year |
|---|---|
Effect of hepatic impairment on the multiple-dose pharmacokinetics of ranolazine sustained-release tablets.
Topics: Acetanilides; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Enzyme Inhibitors; Female; Humans; Liver Diseases; Male; Midazolam; Middle Aged; Piperazines; Ranolazine; Tablets | 2005 |